These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 27008819)

  • 1. RX-TO-OTC SWITCH AND DOUBLE REGISTRATION OCCURRENCE IN POLAND--AN ILLUMINATIVE CASE STUDY.
    Gruchała K; Zimmermann A; Kawczak P
    Acta Pol Pharm; 2016; 73(1):247-54. PubMed ID: 27008819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Issues and Prospects from the OTC Industry vis a vis Pharmaceutical Education and OTC Medicines].
    Nishizawa M
    Yakugaku Zasshi; 2016; 136(7):955-63. PubMed ID: 27374957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over-the-counter medicines: Global perspective and Indian scenario.
    Marathe PA; Kamat SK; Tripathi RK; Raut SB; Khatri NP
    J Postgrad Med; 2020; 66(1):28-34. PubMed ID: 31898596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of nonprescription medicines among elderly patients with chronic illness and their need for pharmacist interventions.
    Guirguis K
    Consult Pharm; 2010 Jul; 25(7):433-9. PubMed ID: 20601348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of pharmacists and student pharmacists in educating and providing advice about over the counter (OTC) medications].
    Kato T
    Yakugaku Zasshi; 2014; 134(2):223-35. PubMed ID: 24492226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing pharmaceutical consultations: Comparing pharmacy-recommended medications for minor ailments and regulatory compliance in a Latin American healthcare network.
    Zavaleta-Monestel E; Villalobos-Madriz JA; Serrano-Arias B; Arguedas-Chacón S; Diaz-Madriz JP; Ferreto-Meza MA; Romero-Chavarría BM; Zumbado-Amerling P
    Explor Res Clin Soc Pharm; 2023 Sep; 11():100300. PubMed ID: 37521020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Misuse of OTC drugs in Poland.
    Zaprutko T; Koligat D; Michalak M; Wieczorek M; Józiak M; Ratajczak M; Szydłowska K; Miazek J; Kus K; Nowakowska E
    Health Policy; 2016 Aug; 120(8):875-81. PubMed ID: 27344198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing student pharmacist impact on patient over-the-counter medication selection.
    McConaha JL; Finoli LM; Heasley JE; Lunney PD
    J Pharm Pract; 2013 Jun; 26(3):280-7. PubMed ID: 23340915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dispensing physicians and prescribing pharmacists: economic considerations for the UK.
    Ryan M; Bond C
    Pharmacoeconomics; 1994 Jan; 5(1):8-17. PubMed ID: 10146862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Strategies to foster an adequate compromise of the pharmacist with respect to over the counter medicines’ advertisement.].
    Armando PD; Tenllado MI; Martínez P; Uema SA
    Rev Fac Cien Med Univ Nac Cordoba; 2018 Nov; 75(4):234-239. PubMed ID: 30734701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From prescription-only (Rx) to over-the-counter (OTC) status in Germany 2006-2015: pharmacological perspectives on regulatory decisions.
    Barrenberg E; Garbe E
    Eur J Clin Pharmacol; 2017 Jul; 73(7):901-910. PubMed ID: 28352949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 'third class' of medications: Sales and purchasing behavior are associated with pharmacist only and pharmacy medicine classifications in Australia.
    Emmerton L
    J Am Pharm Assoc (2003); 2009; 49(1):31-7. PubMed ID: 19196594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Over the counter drugs--a new era in Israel].
    Abadi-Korek I; Vaknin S; Marom E; Shemer J; Luxenburg O
    Harefuah; 2011 Jan; 150(1):29-32, 69, 68. PubMed ID: 21449153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-the-counter drug use by medicare beneficiaries in nursing homes: implications for practice and policy.
    Simoni-Wastila L; Stuart BC; Shaffer T
    J Am Geriatr Soc; 2006 Oct; 54(10):1543-9. PubMed ID: 17038072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifestyle or life-saving medicines? A primary healthcare professional and consumer opinion survey on over-the-counter statins.
    Vamvakopoulos JE; Kountouri M; Marshall T; Greenfield SM
    Ann Pharmacother; 2008 Mar; 42(3):413-20. PubMed ID: 18303145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cross-sectional analysis of over-the-counter codeine use among an Australian sample of people who regularly inject drugs.
    Arora S; Roxburgh A; Bruno R; Nielsen S; Burns L
    Drug Alcohol Rev; 2013 Nov; 32(6):574-81. PubMed ID: 23751176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing access to nonprescription medicines: a global public health challenge and opportunity.
    Hemwall EL
    Clin Pharmacol Ther; 2010 Mar; 87(3):267-9. PubMed ID: 20160746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of over-the-counter medicines’ information and strategies oriented to the community for improving its access and quality.].
    Armando PD; Moscardó MN; Tenllado MI; Uema SAN
    Rev Fac Cien Med Univ Nac Cordoba; 2018 Dec; 75(4):248-254. PubMed ID: 30734703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.